C. Christopher Hook

2.0k total citations
53 papers, 1.1k citations indexed

About

C. Christopher Hook is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, C. Christopher Hook has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 15 papers in Public Health, Environmental and Occupational Health and 11 papers in Genetics. Recurrent topics in C. Christopher Hook's work include Acute Myeloid Leukemia Research (13 papers), Palliative Care and End-of-Life Issues (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). C. Christopher Hook is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Palliative Care and End-of-Life Issues (9 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers). C. Christopher Hook collaborates with scholars based in United States, Democratic Republic of the Congo and Belarus. C. Christopher Hook's co-authors include Paul S. Mueller, Keith M. Swetz, David L. Hayes, Ayalew Tefferi, Mark R. Litzow, Rajiv K. Pruthi, Louis Letendre, Scott H. Kaufmann, Ronald S. Go and Kevin C. Fleming and has published in prestigious journals such as Blood, Annals of Neurology and Mayo Clinic Proceedings.

In The Last Decade

C. Christopher Hook

46 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Christopher Hook United States	17	328	202	179	171	152	53	1.1k
Jan Hofmann United States	11	378 1.2×	159 0.8×	114 0.6×	115 0.7×	77 0.5×	31	814
Soheir Adam United States	17	179 0.5×	65 0.3×	343 1.9×	168 1.0×	116 0.8×	56	1.4k
Tea Reljic United States	21	182 0.6×	96 0.5×	374 2.1×	70 0.4×	243 1.6×	91	1.1k
Lonnie Roy United States	19	64 0.2×	143 0.7×	64 0.4×	112 0.7×	92 0.6×	37	1.3k
Araceli García-González United States	15	149 0.5×	86 0.4×	181 1.0×	83 0.5×	233 1.5×	45	1.0k
Eric Wallace United States	23	251 0.8×	201 1.0×	66 0.4×	42 0.2×	92 0.6×	83	1.6k
Charles G. Martin United States	17	317 1.0×	81 0.4×	118 0.7×	149 0.9×	288 1.9×	26	974
Fiona Mackie Australia	19	197 0.6×	64 0.3×	81 0.5×	338 2.0×	76 0.5×	53	1.3k
John H. Galla United States	23	166 0.5×	72 0.4×	173 1.0×	120 0.7×	86 0.6×	44	1.5k
Jo Wick United States	16	280 0.9×	103 0.5×	56 0.3×	46 0.3×	149 1.0×	67	1.0k

Countries citing papers authored by C. Christopher Hook

Since Specialization

Citations

This map shows the geographic impact of C. Christopher Hook's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Christopher Hook with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Christopher Hook more than expected).

Fields of papers citing papers by C. Christopher Hook

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Christopher Hook. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Christopher Hook. The network helps show where C. Christopher Hook may publish in the future.

Co-authorship network of co-authors of C. Christopher Hook

This figure shows the co-authorship network connecting the top 25 collaborators of C. Christopher Hook. A scholar is included among the top collaborators of C. Christopher Hook based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Christopher Hook. C. Christopher Hook is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ashrani, Aneel A., Michelle A. Elliott, C. Christopher Hook, et al.. (2024). Assessment of Classical Hematologists and Hematology-Focused Fellowship Programs at NCI-Designated Cancer Centers: Implications for Addressing Workforce Shortages and Enhancing Mentorship Opportunities. Blood. 144(Supplement 1). 613–613.

Mangaonkar, Abhishek A., Mrinal M. Patnaik, Aref Al‐Kali, et al.. (2024). Prognostic impact of <i>SF3B1</i> mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases. Haematologica. 109(8). 2525–2532. 1 indexed citations

Tefferi, Ayalew, Naseema Gangat, Aref Al‐Kali, et al.. (2022). A dynamic 3‐factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy. American Journal of Hematology. 97(9). 1127–1134. 6 indexed citations

Tefferi, Ayalew, Naseema Gangat, Mithun Vinod Shah, et al.. (2022). Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience. Haematologica. 107(10). 2474–2479. 1 indexed citations

Begna, Kebede H., Naseema Gangat, Aref Al‐Kali, et al.. (2021). Acute myeloid leukemia after age 70 years: A retrospective comparison of survival following treatment with intensive versus HMA ± venetoclax chemotherapy. American Journal of Hematology. 96(4). E108–E111. 4 indexed citations

Begna, Kebede H., Naseema Gangat, Michelle A. Elliott, et al.. (2021). Mayo Clinic experience with 1123 adults with acute myeloid leukemia. Blood Cancer Journal. 11(3). 46–46. 8 indexed citations

Hsieh, Ronan W., Aishwarya Ravindran, C. Christopher Hook, et al.. (2019). Etiologies of Extreme Thrombocytosis: A Contemporary Series. Mayo Clinic Proceedings. 94(8). 1542–1550. 10 indexed citations

Begna, Kebede H., Naseema Gangat, Michelle A. Elliott, et al.. (2018). A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3‐ITD mutational status. American Journal of Hematology. 93(12). E401–E404. 3 indexed citations

Tefferi, Ayalew, Natasha Szuber, Rangit Vallapureddy, et al.. (2018). Decreased survival and increased rate of fibrotic progression in essential thrombocythemia chronicled after the FDA approval date of anagrelide. American Journal of Hematology. 94(1). 5–9. 9 indexed citations

10.

Ingimarsson, Johann P., et al.. (2016). Successful Percutaneous Nephrolithotomy in Patients with Immune-Mediated Thrombocytopenia Treated with Romiplostim. Journal of Endourology Case Reports. 2(1). 81–83.

11.

Shah, Mithun Vinod, C. Christopher Hook, Timothy G. Call, & Ronald S. Go. (2016). A population-based study of large granular lymphocyte leukemia. Blood Cancer Journal. 6(8). e455–e455. 47 indexed citations

12.

Burkle, Christopher M., Paul S. Mueller, Keith M. Swetz, C. Christopher Hook, & Mark T. Keegan. (2012). Physician perspectives and compliance with patient advance directives: the role external factors play on physician decision making. BMC Medical Ethics. 13(1). 31–31. 34 indexed citations

13.

Elliott, Michelle A., Louis Letendre, Ayalew Tefferi, et al.. (2011). Therapy‐related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy*. European Journal Of Haematology. 88(3). 237–243. 17 indexed citations

14.

Mueller, Paul S., et al.. (2008). Responding to offers of altruistic living unrelated kidney donation by group associations: an ethical analysis. Transplantation Reviews. 22(3). 200–205. 16 indexed citations

15.

Hook, C. Christopher & Paul S. Mueller. (2005). The Terri Schiavo Saga: The Making of a Tragedy and Lessons Learned. Mayo Clinic Proceedings. 80(11). 1449–1460. 28 indexed citations

16.

Elliott, Michelle A., Robert Christian Wolf, C. Christopher Hook, et al.. (2004). Thromboembolism in Adults with Acute Lymphoblastic Leukemia During Induction with L-Asparaginase-containing Multi-agent Regimens: Incidence, Risk Factors, and Possible Role of Antithrombin. Leukemia & lymphoma. 45(8). 1545–1551. 45 indexed citations

17.

Mueller, Paul S., C. Christopher Hook, & David L. Hayes. (2003). Ethical Analysis of Withdrawal of Pacemaker or Implantable Cardioverter-Defibrillator Support at the End of Life. Mayo Clinic Proceedings. 78(8). 959–963. 69 indexed citations

18.

Kilner, John F., et al.. (2002). Cutting-edge bioethics : a Christian exploration of technologies and trends. DigitalGeorgetown (Georgetown University Library).

19.

Tefferi, Ayalew, David P. Steensma, C. Christopher Hook, et al.. (2001). Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndrome. Leukemia Research. 25(2). 183–185. 15 indexed citations

20.

Porrata, Luis F., Steven R. Alberts, C. Christopher Hook, & Curtis A. Hanson. (1999). Idiopathic Thrombocytopenic Purpura Associated With Breast Cancer. American Journal of Clinical Oncology. 22(4). 411–413. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact